MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 10.02.2026
Medpace Holdings EV 2011-2026 | MEDP
EV Jährlich Medpace Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 B | 10.8 B | 11.9 B | 7.96 B | 6.61 B | 5.04 B | 3.44 B | 2.63 B | 1.89 B | 1.56 B | 553 M | 695 M | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 14 B | 553 M | 5.59 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M |  USA |
 |
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Brainsway Ltd.
BWAY
|
223 M | $ 23.08 | 1.7 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 29.14 | -3.75 % | $ 326 M |  China |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
35.7 M | $ 1.1 | 0.46 % | $ 1.4 M | USA |
 |
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
Co-Diagnostics
CODX
|
29.3 M | - | - | $ 79.8 M | USA |
 |
DarioHealth Corp.
DRIO
|
6.61 M | $ 11.38 | 1.16 % | $ 323 M | Israel |
 |
DexCom
DXCM
|
28.2 B | $ 70.29 | 8.0 % | $ 27.4 B | USA |
 |
Celcuity
CELC
|
506 M | $ 103.65 | -1.16 % | $ 4.09 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
665 M | $ 32.89 | 3.09 % | $ 914 M | USA |
 |
Danaher Corporation
DHR
|
150 B | $ 211.14 | -1.74 % | $ 154 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
18.5 B | $ 205.13 | -0.82 % | $ 22.8 B | USA |
 |
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
502 M | $ 23.24 | 1.18 % | $ 703 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
CareDx, Inc
CDNA
|
644 M | $ 19.6 | 2.62 % | $ 1.05 B | USA |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Interpace Biosciences
IDXG
|
19.7 M | $ 1.85 | - | $ 8.12 M | USA |
 |
Exact Sciences Corporation
EXAS
|
12.2 B | $ 103.32 | 0.09 % | $ 19.1 B | USA |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
Lantheus Holdings
LNTH
|
6.44 B | $ 68.71 | -0.02 % | $ 4.75 B | USA |
 |
Guardant Health
GH
|
6.94 B | $ 104.76 | 1.95 % | $ 12.9 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B |  Niderland |
 |
National Research Corporation
NRC
|
1.08 B | $ 12.09 | -5.81 % | $ 297 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
12.4 B | $ 160.2 | 0.91 % | $ 8.23 B | USA |
 |
IDEXX Laboratories
IDXX
|
39.1 B | $ 627.58 | 1.68 % | $ 51.8 B | USA |
 |
Illumina
ILMN
|
15.3 B | $ 115.9 | 1.27 % | $ 18.4 B | USA |
 |
OPKO Health
OPK
|
1.62 B | $ 1.24 | 2.48 % | $ 861 M | USA |
 |
IQVIA Holdings
IQV
|
54.8 B | $ 166.72 | -1.27 % | $ 30.2 B | USA |
 |
Natera
NTRA
|
5.53 B | $ 204.66 | -1.53 % | $ 20.1 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
14.5 B | $ 31.11 | -0.94 % | $ 20 B | Niderland |
|
Biodesix
BDSX
|
142 M | $ 11.55 | 6.6 % | $ 1.5 B | USA |
 |
Personalis
PSNL
|
229 M | $ 8.22 | -2.09 % | $ 487 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
29.9 B | $ 281.39 | 1.13 % | $ 23.6 B | USA |
 |
ICON Public Limited Company
ICLR
|
26.4 B | $ 95.34 | 19.06 % | $ 7.86 B |  Irlanda |
 |
Quidel Corporation
QDEL
|
460 M | $ 23.61 | -0.55 % | $ 995 M | USA |
 |
Biomerica
BMRA
|
6.63 M | $ 2.25 | 4.19 % | $ 5.17 M | USA |
 |
Bioventus
BVS
|
904 M | $ 8.22 | 1.48 % | $ 515 M | USA |